News Archive – Page 12 of 48 – Cambridge Enterprise

Spirea (cancer therapeutics) Dr Adam Collier CBO, Dr Myriam Ouberai CEO founder

Cambridge Enterprise co-leads £2.4m investment in spin-out developing ADC cancer therapeutics

Joint Harvard-Cambridge spin-out closes $50m Series A to drive biomolecular condensate drug discovery

Cambridge Enterprise joins in £18m Series B to speed adoption of sustainable textile dyeing solution

Cambridge Enterprise leads £1m investment in cancer care management device start-up

Cambridge spin-out raises $6m seed round for transformative regulatory data structures

New Head at Cambridge Enterprise Seed Funds

Tenyks AI

Cambridge spin-out secures $3.4m to invent the way humanity interacts with AI

Cambridge spin-out enters $42m partnership to develop ‘future-proofed’ coronavirus vaccines

Cambridge Enterprise joins £2.2m seed round for data-driven infrastructure and construction platform

Semarion's Tarun Vemulkar (CTO) and Jeroen Verheyen (CEO)

Cambridge spin-out Semarion raises £2.14m to commercialise cell assaying platform

22 February 2022

Dr Xavier Moya, co-founder Barocal

Zero-carbon refrigeration pioneer Barocal secures £1.3m funding to explore heating systems

15 February 2022

abstract; reflective surfaces and horizon

Cambridge spin-out secures £2.5m seed round for transformational genomic data management tech

01 February 2022

177-192 of 567

Page of 48